1-4 of 4
Navin K. Chintala
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3993: A tunable safety switch for solid tumor CAR T-cell therapy

Free
Kyohei Misawa, Meriem Taleb, Srijita Banerjee, William-Ray Vista, Navin K. Chintala, Prasad S. Adusumilli
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3993.
https://doi.org/10.1158/1538-7445.AM2024-3993
Published: 22 March 2024
View articletitled, Abstract 3993: A tunable safety switch for solid tumor CAR T-cell therapy
Journal Articles

Abstract LB-378: Regional delivery of clinical-grade mesothelin-targeted CAR T cells with cell-intrinsic PD-1 checkpoint blockade: Translation to a phase I trial

Free
Stefan Kiesgen, Camille Linot, Hue T. Quach, Jasmeen Saini, Rebecca Bellis, Srijita Banerjee, Zhaohua Hou, Navin K. Chintala, Michel Sadelain, Prasad S. Adusumilli
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): LB-378.
https://doi.org/10.1158/1538-7445.AM2020-LB-378
Published: 15 August 2020
View articletitled, Abstract LB-378: Regional delivery of clinical-grade mesothelin-targeted CAR T cells with cell-intrinsic PD-1 checkpoint blockade: Translation to a phase I trial
Journal Articles

Abstract CT036: A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy

Free
Prasad S. Adusumilli, Marjorie G. Zauderer, Valerie W. Rusch, Roisin E. O'Cearbhaill, Amy Zhu, Daniel A. Ngai, Erin McGee, Navin K. Chintala, John C. Messinger, Alain Vincent, Elizabeth F. Halton, Claudia Diamonte, John Pineda, Shanu Modi, Stephen B. Solomon, David R. Jones, Renier J. Brentjens, Isabelle Rivière, Michel Sadelain
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT036.
https://doi.org/10.1158/1538-7445.AM2019-CT036
Published: 01 July 2019
View articletitled, Abstract CT036: A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy
Journal Articles

Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche

Free
Surya Kumari Vadrevu, Navin K. Chintala, Sharad K. Sharma, Priya Sharma, Clayton Cleveland, Linley Riediger, Sasikanth Manne, David P. Fairlie, Wojciech Gorczyca, Othon Almanza, Magdalena Karbowniczek, Maciej M. Markiewski
Journal: Cancer Research
Cancer Res (2014) 74 (13): 3454–3465.
https://doi.org/10.1158/0008-5472.CAN-14-0157
Published: 30 June 2014
View articletitled, Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
Open the PDF for Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche in another window
Includes: Supplementary data